Pharmacoeconomic analysis of everolimus immunosuppressive therapy for <i>de novo</i> kidney transplant recipients in Russia

Pharmacoeconomic analysis of everolimus immunosuppressive therapy for <i>de novo</i> kidney transplant recipients in Russia

Currently, patients after kidney transplantation can receive mycophenolate mofetil (MPM), mycophenolic acid (MPA), cyclosporine (CSA) and tacrolimus (TAC) through the Federal High-cost Nosologies Program (VZN) in Russia. Use of everolimus (EVL) in combination with a reduced dose of calcineurin inhib...

Full description

Bibliographic Details
Main Authors: N. A. Avxentyev, E. V. Derkach, E. I. Prokopenko
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2019-05-01
Series:Vestnik Transplantologii i Iskusstvennyh Organov
Subjects:
kidney transplantation
immunosuppressive therapy
everolimus
mycophenolic acid
cyclosporine
tacrolimus
cost minimization
budget impact analysis
Online Access:https://journal.transpl.ru/vtio/article/view/986

Internet

https://journal.transpl.ru/vtio/article/view/986

Similar Items